These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9370384

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Overflow of endogenous norepinephrine from PVH nucleus of DOCA-salt hypertensive rats.
    Qualy JM, Westfall TC.
    Am J Physiol; 1995 Apr; 268(4 Pt 2):H1549-54. PubMed ID: 7733356
    [Abstract] [Full Text] [Related]

  • 24. Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats.
    Bae EH, Kim IJ, Ma SK, Kim SW.
    Regul Pept; 2009 Oct 09; 157(1-3):76-83. PubMed ID: 19422859
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Rostafuroxin ameliorates endothelial dysfunction and oxidative stress in resistance arteries from deoxycorticosterone acetate-salt hypertensive rats: the role of Na+K+-ATPase/ cSRC pathway.
    Wenceslau CF, Rossoni LV.
    J Hypertens; 2014 Mar 09; 32(3):542-54. PubMed ID: 24309491
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Importance of chloride for deoxycorticosterone acetate-salt hypertension in the rat.
    Passmore JC, Whitescarver SA, Ott CE, Kotchen TA.
    Hypertension; 1985 Mar 09; 7(3 Pt 2):I115-20. PubMed ID: 3997231
    [Abstract] [Full Text] [Related]

  • 29. Digoxin amplifies the effects of deoxycorticosterone acetate (DOCA) in intact water-drinking rats: implications for the mechanism of DOCA hypertension?
    Li M, Martin A, Liu DT, Whitworth JA.
    J Hypertens; 1994 May 09; 12(5):569-76. PubMed ID: 7930557
    [Abstract] [Full Text] [Related]

  • 30. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM, Chen CC, Chang NC.
    Clin Sci (Lond); 2012 Oct 09; 123(7):445-57. PubMed ID: 22507072
    [Abstract] [Full Text] [Related]

  • 31. Rat skeletal muscle in culture expresses the alpha1 but not the alpha2 protein subunit isoform of the Na+/K+ pump.
    Sharabani-Yosef O, Bak A, Langzam L, Lui Z, Nir U, Braiman L, Sweadner KJ, Sampson SR.
    J Cell Physiol; 1999 Aug 09; 180(2):236-44. PubMed ID: 10395293
    [Abstract] [Full Text] [Related]

  • 32. Sodium pump activity and norepinephrine responsiveness of femoral arterial smooth muscle from DOCA-salt rats.
    Soltis EE, Field FP.
    Pharmacology; 1987 Aug 09; 34(2-3):104-10. PubMed ID: 3588654
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. p38 mitogen-activated protein kinase contributes to the diminished aortic contraction by endothelin-1 in DOCA-salt hypertensive rats.
    Kim B, Kim J, Bae YM, Cho SI, Kwon SC, Jung JY, Park JC, Ahn HY.
    Hypertension; 2004 May 09; 43(5):1086-91. PubMed ID: 15051668
    [Abstract] [Full Text] [Related]

  • 35. Endothelium-derived relaxing factor responses in Doca-salt hypertensive rats.
    Kirchner KA, Scanlon PH, Dzielak DJ, Hester RL.
    Am J Physiol; 1993 Sep 09; 265(3 Pt 2):R568-72. PubMed ID: 8214147
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake.
    Vallee SM, Grillo CA, Gonzalez S, Cosen-Binker L, de Kloet ER, McEwen BS, De Nicola AF.
    Neuroendocrinology; 1995 Feb 09; 61(2):117-24. PubMed ID: 7753331
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.